Matches in DBpedia 2016-04 for { ?s ?p "Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) undergoing clinical trials for the treatment of cancer.HGS-ETR2 antibodies were generated by HGS through a collaboration with Cambridge Antibody Technology."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Lexatumumab abstract "Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) undergoing clinical trials for the treatment of cancer.HGS-ETR2 antibodies were generated by HGS through a collaboration with Cambridge Antibody Technology.".
- Q1112374 abstract "Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) undergoing clinical trials for the treatment of cancer.HGS-ETR2 antibodies were generated by HGS through a collaboration with Cambridge Antibody Technology.".
- Lexatumumab comment "Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) undergoing clinical trials for the treatment of cancer.HGS-ETR2 antibodies were generated by HGS through a collaboration with Cambridge Antibody Technology.".
- Q1112374 comment "Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) undergoing clinical trials for the treatment of cancer.HGS-ETR2 antibodies were generated by HGS through a collaboration with Cambridge Antibody Technology.".